ArticleThe plant pathology journal2026
Potent Bacteriostatic Activity of a Naphthalene-2-Acyl Imidazolium Salt against Xanthomonas oryzae pv. oryzae.
Article in The plant pathology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Synthesis, Antibacterial Evaluation, and Chemometric Profiling of a Vanilloid-Based Compounds Library Active AgainstAntibiotics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rice bacterial leaf blight caused by Xanthomonas oryzae pv. oryzae (Xoo) remains a serious yield threat. To identify selective antibacterials, we synthesized a small library of naphthalene-2-acyl imidazolium salts (NAIMSs) and evaluated their anti-Xoo activity. Diskdiffusion assays of 18 analogues revealed a clear structure-activity relationship: isopentyloxy-substituted derivatives were active, whereas others were not. Among them, NAIMS1f exhibited potent inhibition with a minimum inhibitory concentration of 0.75 μg mL-1. Growth kinetics demonstrated bacteriostatic action, completely suppressing low-inoculum growth but not killing high-density cultures. NAIMS1f showed higher sensitivity toward Xoo than Escherichia coli, Bacillus pumilus, or Pseudomonas syringae, defining a useful sensitivity window. These findings identify NAIMS1f as a promising lead for Xoo-focused inhibition in vitro and provide a basis for future mechanistic and pre-field validation studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.